Form 4 Filing for Christine Ring

Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NRIX), reported transactions on August 3, 2026. Ring acquired 5,787 shares of Common Stock at a price of $8.72 per share, increasing her direct ownership to 25,699 shares. Concurrently, she disposed of 16,589 shares of Common Stock at a weighted average price of $23.0489, with sales ranging from $22.67 to $23.30, reducing her direct ownership to 9,110 shares. Additionally, Ring exercised an employee stock option (right to buy) for 5,787 shares of Common Stock at a price of $0.00, with an exercise price of $8.72 per share. This transaction resulted in her holding 122,824 shares. All transactions were executed under a Rule 10b5-1 trading plan.